Hunan Er-Kang Pharmaceutical Co. Ltd. announced earnings results for the half year ended June 30, 2020. For the half year, the company announced sales was CNY 1,202.263 million compared to CNY 1,350.909 million a year ago. Operating income was CNY 74.687 million compared to CNY 149.217 million a year ago. Net income was CNY 66.152 million compared to CNY 129.225 million a year ago. Basic earnings per share from continuing operations was CNY 0.0321 compared to CNY 0.0627 a year ago.